Tag: VenaSeal
Spectrum Program highlights VenaSeal closure system’s importance in treating superficial venous...
“I would challenge anybody who says that VenaSeal is investigational. It’s a robust, well-evaluated, very well studied intervention that I think we would all...
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a...
VeClose trial reports “excellent” clinical and quality of life outcomes at...
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up...
VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation
Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using...
WAVES trial shows 100% vein closure at one month with short...
A post-market evaluation of the VenaSeal closure system (Medtronic) has found that, at one month, 100% of treated veins remained closed, quality of life...